...
首页> 外文期刊>Transfusion: The Journal of the American Association of Blood Banks >Stored platelets alter glycerophospholipid and sphingolipid species, which are differentially transferred to newly released extracellular vesicles
【24h】

Stored platelets alter glycerophospholipid and sphingolipid species, which are differentially transferred to newly released extracellular vesicles

机译:储存的血小板改变了甘油磷脂和鞘脂的种类,它们被差异地转移到新释放的细胞外囊泡中

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Stored platelet concentrates (PLCs) for transfusion develop a platelet storage lesion (PSL), resulting in decreased platelet (PLT) viability and function. The processes leading to PSL have not been described in detail and no data describe molecular changes occurring in all three components of stored PLCs: PLTs, PLC extracellular vesicles (PLC-EVs), and plasma. Study Desing and Methods: Fifty PLCs from healthy individuals were stored under standard blood banking conditions for 5 days. Changes in cholesterol, glycerophospholipid, and sphingolipid species were analyzed in PLTs, PLC-EVs, and plasma by mass spectrometry and metabolic labeling. Immunoblots were performed to compare PLT and PLC-EV protein expression. Results: During 5 days, PLTs transferred glycerophospholipids, cholesterol, and sphingolipids to newly formed PLC-EVs, which increased corresponding lipids by 30%. Stored PLTs significantly increased ceramide (Cer; +53%) and decreased sphingosine-1-phosphate (-53%), shifting sphingolipid metabolism toward Cer. In contrast, plasma accumulated minor sphingolipids. Compared to PLTs, fresh PLC-EVs were enriched in lysophosphatidic acid (60-fold) and during storage showed significant increases in cholesterol, sphingomyelin, dihydrosphingomyelin, plasmalogen, and lysophosphatidylcholine species, as well as accumulation of apolipoproteins A-I, E, and J/clusterin. Conclusion: This is the first detailed analysis of lipid species in all PLC components during PLC storage, which might reflect mechanisms active during in vivo PLT senescence. Stored PLTs reduce minor sphingolipids and shift sphingolipid metabolism toward Cer, whereas in the plasma fraction minor sphingolipids increase. The composition of PLC-EVs resembles that of lipid rafts and confirms their role as carriers of bioactive molecules and master regulators in vascular disease. ? 2012 American Association of Blood Banks.
机译:背景:用于输血的储存的血小板浓缩液(PLC)会发展为血小板储存病变(PSL),导致血小板(PLT)活力和功能降低。尚未详细描述导致PSL的过程,也没有数据描述在存储的PLC的所有三个组件中发生的分子变化:PLT,PLC细胞外囊泡(PLC-EV)和血浆。研究目的和方法:将五十名来自健康个体的PLC在标准血库条件下保存5天。通过质谱和代谢标记分析了PLT,PLC-EV和血浆中胆固醇,甘油磷脂和鞘脂种类的变化。进行免疫印迹以比较PLT和PLC-EV蛋白表达。结果:在5天内,PLT将甘油磷脂,胆固醇和鞘脂转移至新形成的PLC-EV,使相应的脂质增加30%。储存的PLT显着增加了神经酰胺(Cer; + 53%)并降低了鞘氨醇-1-磷酸(-53%),使鞘脂代谢向Cer转移。相反,血浆中积累了少量的鞘脂。与PLT相比,新鲜的PLC-EV富含溶血磷脂酸(60倍),并且在储存过程中胆固醇,鞘磷脂,二氢鞘磷脂,缩醛磷脂和溶血磷脂酰胆碱种类显着增加,并且载脂蛋白AI,E和J /簇蛋白。结论:这是对PLC储存期间所有PLC组件中脂质种类的首次详细分析,这可能反映了体内PLT衰老过程中的活跃机制。储存的PLT会减少少量的鞘脂并使鞘脂代谢向Cer转移,而在血浆中,少量的鞘脂会增加。 PLC-EV的组成类似于脂质筏,并证实了它们在血管疾病中作为生物活性分子的载体和主要调节剂的作用。 ? 2012年美国血库协会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号